Myrna Mendoza
Overview
Explore the profile of Myrna Mendoza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang Y, Coombs G, Ling T, Balaji V, Rodrigues C, Mikamo H, et al.
Int J Antimicrob Agents
. 2017 Apr;
49(6):734-739.
PMID: 28435019
This study was conducted to investigate the epidemiology and antimicrobial susceptibility patterns of Gram-negative bacilli (GNB) isolated from intra-abdominal infections (IAIs) in the Asia-Pacific region (APR) from 2010-2013. A total...
2.
Jean S, Coombs G, Ling T, Balaji V, Rodrigues C, Mikamo H, et al.
Int J Antimicrob Agents
. 2016 Mar;
47(4):328-34.
PMID: 27005459
A total of 9599 isolates of Gram-negative bacteria (GNB) causing urinary tract infections (UTIs) were collected from 60 centres in 13 countries in the Asia-Pacific region from 2010-2013. These isolates...
3.
Tan T, Hsu L, Alejandria M, Chaiwarith R, Chinniah T, Chayakulkeeree M, et al.
Med Mycol
. 2016 Feb;
54(5):471-7.
PMID: 26868904
Bloodstream infections caused by Candida species are of increasing importance and associated with significant mortality. We performed a multi-centre prospective observational study to identify the species and antifungal susceptibilities of...
4.
Jean S, Ko W, Xie Y, Pawar V, Zhang D, Prajapati G, et al.
Int J Antimicrob Agents
. 2014 Aug;
44(3):222-8.
PMID: 25106073
In this prospective, observational, multicentre study using data from five countries (Columbia, The Philippines, Portugal, Taiwan and Thailand), the clinical impact of extended-spectrum β-lactamase (ESBL)-producing organisms on hospitalised patients with...
5.
Mendes R, Mendoza M, Banga Singh K, Castanheira M, Bell J, Turnidge J, et al.
Antimicrob Agents Chemother
. 2013 Aug;
57(11):5721-6.
PMID: 23959306
The Regional Resistance Surveillance program monitored susceptibility rates and developing resistance by geographic region, including 12 Asia-Pacific (APAC) countries. Reference broth microdilution methods for susceptibility/interpretations were applied, processing 5,053 strains....
6.
Hui D, Ip M, Ling T, Chang S, Liao C, Yoo C, et al.
Respirology
. 2011 Feb;
16(3):532-9.
PMID: 21299688
Background And Objective: Antimicrobial resistance is a global problem and the prevalence is high in many Asian countries. Methods: A prospective observational study of the prevalence of bacterial pathogens and...
7.
Bravo L, Tuohy M, Ang C, Destura R, Mendoza M, Procop G, et al.
J Clin Microbiol
. 2009 Oct;
47(12):3985-90.
PMID: 19846642
After isoniazid and rifampin (rifampicin), the next pivotal drug class in Mycobacterium tuberculosis treatment is the fluoroquinolone class. Mutations in resistance-determining regions (RDR) of the rpoB, katG, and gyrA genes...
8.
Litzow J, Gill C, Mantaring J, Fox M, MacLeod W, Mendoza M, et al.
Infect Control Hosp Epidemiol
. 2009 May;
30(6):543-9.
PMID: 19435448
Background: Although hospital-acquired infections appear to be a growing threat to the survival of newborns in the developing world, the epidemiology of this problem remains poorly characterized. Methods: During a...
9.
Gill C, Mantaring J, MacLeod W, Mendoza M, Mendoza S, Huskins W, et al.
Clin Infect Dis
. 2008 Nov;
48(1):13-21.
PMID: 19025496
Background: The growing burden of neonatal mortality associated with hospital-acquired neonatal sepsis in the developing world creates an urgent need for cost-effective infection-control measures in resource-limited settings. Methods: Using a...